38 yr old man with Evng rise of temperature, bsbk and waist pain , preorbital pain tinnitus ear and pain in the gum

Reading File
This is a complex clinical scenario. Let me search the medical library with parallel queries.
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Excellent - Brucellosis is a strong hit. Let me read the clinical features section from Harrison's and Goldman-Cecil in parallel.
Reading File
Reading File
I now have very rich content. Let me read the clinical features section from Harrison's which had the key passage about evening fever distinguishing brucellosis.
Reading File
Reading File
I have comprehensive data. Let me now read the Harrison's clinical features section specifically about the evening fever distinction.
Reading File
Finding Sources
I have all the information needed. Now let me compile a comprehensive clinical answer.

Clinical Analysis: 38-Year-Old Male with Evening Rise of Temperature

Decoding the Presenting Complaints

SymptomClinical Significance
Evening rise of temperatureClassic "undulant fever" pattern
Back/waist pain (bsbk)Lumbar spondylitis / sacroiliitis
Periorbital painCephalgia/sinus involvement or neurobrucellosis
Tinnitus + ear painOtological involvement (neurobrucellosis)
Gum painOropharyngeal involvement / hematogenous spread

Most Likely Diagnosis: BRUCELLOSIS (Undulant Fever)

This constellation is a textbook presentation of acute/subacute brucellosis. The pattern is recognized as one of three classical presentations: "long-lasting fever, misery, and low-back or hip pain in an older person (especially men)".
"Two features recognized in the nineteenth century distinguish brucellosis from other tropical fevers, such as typhoid and malaria: (1) the fever of brucellosis shows an undulating pattern...persists for weeks...followed by relapse; (2) the fever of brucellosis is associated with musculoskeletal symptoms and signs in about one-half of all patients."
  • Harrison's Principles of Internal Medicine 22E (2025)

Why Each Feature Fits

1. Evening Rise of Temperature ("Undulant Fever")
  • Brucellosis is nicknamed undulant fever because of its remittent, wave-like fever pattern - often peaking in the evenings with drenching night sweats.
  • Fever > 39.4°C occurs in 95% of patients; a relative bradycardia (pulse-temperature dissociation) may also be present.
2. Back and Waist Pain
  • Osteoarticular involvement occurs in ~40% of cases.
  • Sacroiliitis is the most common acute presentation; lumbar spondylitis/spondylodiscitis in the lumbar area is the next most frequent.
  • In endemic areas, a man with fever + difficulty walking is suspected to have brucellosis until proven otherwise.
  • Goldman-Cecil notes: "Among osteoarticular complications, sacroiliitis is the most common acute presentation."
3. Periorbital Pain
  • Ocular pain and blurring of vision occur in a subset of patients, representing either direct orbital/ocular brucellosis or part of neurobrucellosis.
  • Up to 10% of men develop epididymo-orchitis; similarly, genitourinary and neurological spread is well documented.
4. Tinnitus and Ear Pain
  • Neurobrucellosis affects the CNS/peripheral nervous system including cranial nerves, causing sensorineural hearing loss and tinnitus.
  • Any cranial nerve may be affected; vestibulo-cochlear involvement causes tinnitus, vertigo, and ear pain.
5. Gum Pain
  • Oropharyngeal route is a recognized entry point (consumption of unpasteurized dairy, soft cheeses).
  • Lymphadenopathy (cervical, axillary) is present in ~14% of patients, and oropharyngeal/gingival lesions reflect hematogenous seeding or local entry.

Differential Diagnosis to Consider

ConditionFeatures in CommonDistinguishing Against
Typhoid feverFever, malaise, back painNo undulating pattern; rose spots; diarrhea; no joint/ear involvement typically
TuberculosisBack pain, fever, night sweatsProductive cough, more pulmonary signs; lumbar TB causes gibbus/cord compression (rare in brucellosis)
MalariaEvening/night fever, myalgiaCyclical rigors (tertian/quartan); splenomegaly more prominent; no joint/ear/gum features
Infective endocarditisFever, musculoskeletal painHeart murmur, embolic phenomena; Osler nodes
LeptospirosisFever, myalgia, headacheConjunctival suffusion, renal involvement, Weil's disease

Key History Questions to Ask

  1. Occupation: Farmer, veterinarian, abattoir/slaughterhouse worker, laboratory worker?
  2. Diet: Unpasteurized milk, soft goat/sheep cheese (feta, brie), raw/undercooked meat?
  3. Travel: Endemic area (Middle East, Mediterranean, Central Asia, Sub-Saharan Africa, Latin America)?
  4. Animal contact: Cattle, sheep, goats, camels, swine, dogs?
  5. Similar illness in family members (documented in ~50% of household cases in endemic areas)?

Investigations

InvestigationFinding in Brucellosis
Standard Agglutination Test (SAT) / Wright's testTitre ≥ 1:160 is significant; ≥ 1:320 highly suggestive
Blood culture / Bone marrow cultureGold standard; sensitivity 10-85% depending on species; alert lab to biosafety risk
CBCMild anemia, lymphopenia, neutropenia, thrombocytopenia
Liver enzymesMay be mildly elevated (hepatic involvement ~25%)
MRI lumbar spineAnterior end-plate erosions, spondylodiscitis (early finding)
PCR / NAATHighly accurate, rapid; cannot confirm cure
Rose Bengal testRapid screening - sensitive but less specific

Treatment

First-line regimens (per Harrison's 22E and Goldman-Cecil):
Option 1 (WHO preferred):
  • Doxycycline 100 mg BD x 6 weeks + Rifampicin 600-900 mg OD x 6 weeks
Option 2 (for severe/complicated disease - spondylitis, neurobrucellosis):
  • Doxycycline + Streptomycin (or Gentamicin) IM for initial 2-3 weeks, then switch to doxycycline + rifampicin to complete 3-6 months
For neurobrucellosis/spondylitis: Extend total therapy to 3-6 months; add a third agent (co-trimoxazole or fluoroquinolone) for CNS involvement.
"With early antimicrobial therapy, brucellosis is usually cured, and cases of relapsing brucellosis, chronic brucellosis, or localized complications are rare."
  • Goldman-Cecil Medicine

Red Flags Requiring Urgent Evaluation

  • Focal neurological signs (neurobrucellosis - can cause meningitis, encephalitis)
  • Cardiac involvement (Brucella endocarditis - rare but high mortality)
  • Severe thrombocytopenia or pancytopenia
  • Spinal cord compression signs

Sources:
  • Harrison's Principles of Internal Medicine 22E (2025), Chapter 174: Brucellosis
  • Goldman-Cecil Medicine, Chapter 286: Brucellosis
  • Medical Microbiology 9e, Clinical Case 29.3

Management steps

Searching sources...
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Excellent - I now have the full treatment table from Goldman-Cecil. Let me read the rest of the treatment section.
Reading File
Reading File
I now have everything needed for a complete, step-by-step management plan. Here it is:

Management of Brucellosis - Step-by-Step


STEP 1: CLINICAL ASSESSMENT & RISK STRATIFICATION

History (critical for diagnosis)
  • Occupational exposure: farmer, veterinarian, abattoir worker, lab personnel?
  • Dietary: unpasteurized milk, soft goat/sheep cheese, undercooked meat?
  • Travel to endemic area (Middle East, Mediterranean, South Asia, Africa)?
  • Duration of symptoms (determines acute vs subacute vs chronic classification)
Assess for complications - these change management:
ComplicationClinical Clues
Spondylitis / sacroiliitisSevere back/waist pain - present in this patient
NeurobrucellosisTinnitus, periorbital pain, cranial nerve signs - present in this patient
Orchitis/epididymitisTesticular pain (up to 10% of men)
EndocarditisNew murmur, embolic signs
HepatosplenomegalyAbdominal pain, fullness
This patient has features suggestive of both spondylitis (back/waist pain) and possible neurobrucellosis (tinnitus + periorbital pain) - this classifies him as COMPLICATED brucellosis, requiring longer therapy.

STEP 2: INVESTIGATIONS

Confirm Diagnosis
TestDetails
Serum Agglutination Test (SAT / Wright's test)Titre ≥ 1:160 in endemic areas is presumptive; 4-fold rise over 2 weeks is significant
Rose Bengal testRapid screening - sensitive but less specific
Blood culture x 3Alert lab to Brucella risk (biohazard). Sensitivity 10-85%; Bactec systems positive within 7 days
Bone marrow cultureMore sensitive than blood culture, especially for B. melitensis
PCR (NAAT)Most rapid and sensitive; cannot confirm cure (DNA persists)
IgG/IgM ELISAUseful in chronic/relapsing disease where SAT may be negative
Brucella Coombs testFor chronic cases with negative SAT (detects non-agglutinating antibodies)
Assess Organ Involvement
InvestigationPurpose
CBCAnemia, leukopenia, lymphocytosis, thrombocytopenia
LFTsHepatic involvement (~25% of cases)
ESR, CRPUsually raised in complicated disease
MRI lumbar spineEarly spondylodiscitis: anterior end-plate erosions; paravertebral/psoas abscess
MRI brain + CSFIf neurobrucellosis suspected - lymphocytosis + low glucose in CSF
EchocardiographyIf endocarditis suspected
Isotope bone scanMore sensitive than plain X-ray; positive even after treatment

STEP 3: ANTIMICROBIAL THERAPY

This patient is COMPLICATED (probable spondylitis + neurobrucellosis features) - needs triple therapy and extended duration.

A. Uncomplicated Acute Brucellosis (for reference)

Gold standard (WHO preferred):
  • Doxycycline 100 mg PO BD x 6 weeks + Streptomycin 1 g IM OD x 2-3 weeks
Alternative (more convenient, slightly higher relapse rate ~10-20%):
  • Doxycycline 100 mg PO BD x 6 weeks + Rifampicin 600-900 mg PO OD x 6 weeks
If streptomycin unavailable:
  • Doxycycline 200 mg/day x 6 weeks + Gentamicin 3-5 mg/kg/day IM x 1-2 weeks

B. Complicated Brucellosis - Spondylitis / Sacroiliitis (this patient)

  • Duration extended to 3 months minimum
  • Triple regimen: Doxycycline + Rifampicin + initial Aminoglycoside (Gentamicin x 2 weeks)
  • Monitor MRI spine for response

C. Neurobrucellosis (if confirmed by CSF/MRI)

  • Duration 3-6 months
  • Doxycycline 200 mg/day + Rifampicin 600-900 mg/day + TMP-SMX (co-trimoxazole) for 6+ weeks
  • Can add Ceftriaxone 2 g IV q12h x 6 weeks (substitutes for one oral agent - better CNS penetration)
  • Steroids may be considered in severe neurobrucellosis with inflammation
"Focal neurologic disease due to Brucella requires prolonged treatment for 3-6 months, usually with ceftriaxone supplementation of a standard two-drug regimen." - Harrison's 22E

STEP 4: SUPPORTIVE MANAGEMENT

  • Analgesics / NSAIDs for musculoskeletal pain (back, sacroiliac joints)
  • Bed rest in the acute phase; gradual mobilization
  • Spinal immobilization/bracing if significant spondylodiscitis on MRI
  • Physiotherapy for back pain rehabilitation after acute phase settles
  • Neurology referral if confirmed neurobrucellosis
  • Orthopedics referral if spinal abscess (paravertebral/psoas) requiring surgical drainage

STEP 5: MONITORING & FOLLOW-UP

ParameterSchedule
Clinical reassessmentWeekly for first month
SAT serologyAt 3 months and 6 months; falling titres confirm response
CBC, LFTsMonthly (drug toxicity monitoring - rifampicin hepatotoxicity, doxycycline GI effects)
MRI spine repeatAt 6-8 weeks if spondylitis; document healing
Watch for relapseOccurs in 5-10% with gold-standard regimen; up to 20% with doxycycline + rifampicin
Signs of relapse (usually 2-3 months after completing therapy):
  • Return of fever, sweats, malaise
  • Rising SAT titres
  • Positive blood culture
  • Treat relapse with the same or alternative two-drug regimen for a full 6 weeks

STEP 6: PREVENT COMPLICATIONS & SPECIAL SITUATIONS

SituationAction
Brucella endocarditisBactericidal drugs (fluoroquinolone + aminoglycoside + beta-lactam); early cardiac surgery (valve replacement) - 84% of brucellosis deaths involve endocarditis
Abscess (psoas, paravertebral, splenic)Surgical drainage + antibiotics ≥6 weeks
Prosthetic joint infection~75% need debridement or revision + antibiotics

STEP 7: INFECTION CONTROL & PREVENTION

  • Notify public health authorities (notifiable disease in many countries)
  • Identify source of infection (animal contact, food source)
  • Screen family members and occupational contacts
  • Avoid unpasteurized dairy products going forward
  • Protective equipment if occupational exposure continues

Summary Drug Chart for This Patient

DrugDoseRouteDurationRole
Doxycycline100 mg BDOral3 monthsBackbone
Rifampicin600 mg ODOral3 monthsSecond agent
Gentamicin5 mg/kg/dayIM2 weeks (initial)Third agent / aminoglycoside coverage
Ceftriaxone2 g q12hIV4-6 weeksAdd if neurobrucellosis confirmed
Co-trimoxazole960 mg BDOral3 monthsIf CNS involvement
"Complex or focal disease may necessitate ≥3 months of therapy. Adherence is very important - poor adherence underlies almost all cases of apparent treatment failure." - Harrison's 22E

Sources: Harrison's Principles of Internal Medicine 22E (2025), Ch. 174 | Goldman-Cecil Medicine, Ch. 286 | Red Book 2021 (AAP Committee on Infectious Diseases)
This is a shared conversation. Sign in to Orris to start your own chat.